GIS
37
3
L
55
-3
CA
32
-12
AON
32
-2
PYPL
60
-2
GOOG
83
-4
EW
55
14
GLW
45
4
RIG
49
-5
ALLE
35
-2
BDX
60
6
KO
46
4
DTE
45
-2
FMC
39
-4
CCL
70
-2
ALL
35
-2
TSN
30
-2
CAT
55
-3
HAL
39
-2
ADI
59
2
GIS
37
3
L
55
-3
CA
32
-12
AON
32
-2
PYPL
60
-2
GOOG
83
-4
EW
55
14
GLW
45
4
RIG
49
-5
ALLE
35
-2
BDX
60
6
KO
46
4
DTE
45
-2
FMC
39
-4
CCL
70
-2
ALL
35
-2
TSN
30
-2
CAT
55
-3
HAL
39
-2
ADI
59
2
Financhill
Back

Centessa Pharmaceuticals PLC Quote, Financials, Valuation and Earnings

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
77

CNTA
Centessa Pharmaceuticals PLC

Last Price:
16.54
Seasonality Move:
8.39%

7 Day Trial

ALL ACCESS PASS

$ 7

The dark truth about AI

Click here to learn more...

Centessa Pharmaceuticals PLC Price Quote

$16.54
-0.33 (-1.96%)
(Updated: December 13, 2024 at 5:55 PM ET)

Centessa Pharmaceuticals PLC Key Stats

Buy
77
Centessa Pharmaceuticals PLC (CNTA) is a Buy
Day range:
$16.41 - $17.34
52-week range:
$6.65 - $18.97
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.46%
Volume:
1.1M
Avg. volume:
668.1K
1-year change:
163.59%
Market cap:
$2.2B
Revenue:
$6.9M
EPS:
$-1.52

How Much Does Centessa Pharmaceuticals PLC Make?

Data Unavailable

Is Centessa Pharmaceuticals PLC Growing As A Company?

Data Unavailable

Centessa Pharmaceuticals PLC Stock Price Performance

What Is Centessa Pharmaceuticals PLC 52-Week High & Low?

Centessa Pharmaceuticals PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Centessa Pharmaceuticals PLC?

Is Centessa Pharmaceuticals PLC Cash Flow Positive?

  • What Is CNTA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$130.3M
  • What Is Centessa Pharmaceuticals PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $368.2M
  • What Is Centessa Pharmaceuticals PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$12M

Centessa Pharmaceuticals PLC Return On Invested Capital

Data Unavailable

Centessa Pharmaceuticals PLC Earnings Date & Stock Price

Centessa Pharmaceuticals PLC Competitors

Centessa Pharmaceuticals PLC Dividend Yield

Centessa Pharmaceuticals PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 4.52%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 28.57
Upside from Last Price: 69.36%

Major Shareholders

  • How many CNTA shares are owned by institutional investors?
    118.5M CNTA shares are owned by institutional investors
  • How many CNTA shares are owned by insiders?
    3.7M CNTA shares are owned by insiders